News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Merck & Co., Inc. Says Some Vioxx Suits May Be Settled
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Merck & Co. might consider settling some lawsuits over its painkiller Vioxx, whose links to heart trouble have spawned thousands of lawsuits and a $253 million jury verdict, a spokesman for the company's legal team said Friday.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Merck & Co.
MORE ON THIS TOPIC
FDA
Unforced errors flummox HHS’ radical transparency bid—again
May 6, 2026
·
6 min read
·
Heather McKenzie
Patents
Pfizer settles with generic drugmakers to protect blockbuster drug until 2031
April 29, 2026
·
2 min read
·
Nick Paul Taylor
Pancreatic cancer
Revolution levels legal threat on Erasca as pancreatic cancer rivalry heats up
April 28, 2026
·
3 min read
·
Tristan Manalac
Drug pricing
Regeneron finally joins Trump’s drug pricing push while notching landmark approval
April 24, 2026
·
2 min read
·
Tristan Manalac
